Vonlerolizumab Biosimilar – Anti-TNFRSF4, CD134 mAb – Research Grade

Reference:
Size

,

Isotype

IgG1, kappa

Brand

Product type

Clonality

Expression system

Applications

,

Product nameVonlerolizumab Biosimilar - Anti-TNFRSF4, CD134 mAb - Research Grade
SourceCAS 1638935-72-4
SpeciesHumanized
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
Aliases /SynonymsVonlerolizumab,MOXR-0916,MOXR0916,RG-7888,RO7021608,TNFRSF4, CD134,anti-TNFRSF4, CD134
ReferencePX-TA1424
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG1-kappa
ClonalityMonoclonal Antibody

Description of Vonlerolizumab Biosimilar - Anti-TNFRSF4, CD134 mAb - Research Grade

General information on Anti-TNFRSF4/CD134[Homo sapiens] (Vonlerolizumab) Monoclonal Antibody

Vonlerolizumab is investigated for thr treatment of Locally Advanced or Metastatic Urothelial Carcinoma.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Vonlerolizumab Biosimilar – Anti-TNFRSF4, CD134 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

Human OX40 recombinant protein
Antigen

Human OX40 recombinant protein

PX-P6017 500$
Human IgG1 LALA Isotype Control antibody (HyHEL-10)
Isotype Control

Human IgG1 LALA Isotype Control antibody (HyHEL-10)

PTX17885 214$

Contact us

Send us a message from the form below







    Cart (0 Items)

    Your cart is currently empty.

    View Products